LifeSensors (United States)

2024–2025 · research · R43

Molecular glue degraders for LRRK2

Karteek Kadimisetty · LifeSensors (United States) · funded by National Institutes of Health

$300kProtein Degradation and Inhibitors

2021 · research · Fall 2021 RFP: Outcome Measures

Exploring the Role of Faulty Protein Degradation as a Cause of Parkinson’s Disease

Karteek Kadimisetty · LifeSensors (United States) · funded by Michael J. Fox Foundation for Parkinson's Research

2020–2026 · research · R44

Novel Approaches for Tau PROTAC Drug Discovery

Tauseef R. Butt · LifeSensors (United States) · funded by National Institutes of Health

$1.2MProtein Degradation and Inhibitors

2020–2025 · research · R44

Novel Approaches for Tau PROTAC Drug Discovery

Karteek Kadimisetty · LifeSensors (United States) · funded by National Institutes of Health

$1.3MProtein Degradation and Inhibitors

2020–2022 · research · R43

Novel Approaches for PROTAC Drug Discovery

Karteek Kadimisetty · LifeSensors (United States) · funded by National Institutes of Health

$397.1kProtein Degradation and Inhibitors

2020–2022 · research · R43

Development of Non-conventional PROTACs

Bryant Darnay · LifeSensors (United States) · funded by National Institutes of Health

$300kProtein Degradation and Inhibitors

2019–2024 · research · R44

Rational design of bifunctional protein degrader drugs

Karteek Kadimisetty · LifeSensors (United States) · funded by National Institutes of Health

$733.6kProtein Degradation and Inhibitors

2019–2021 · research · R43

Determining the signatures of pan-ubiquitylation in the immune proteome as highly sensitive and effective markers for neurodegenerative disease

Karteek Kadimisetty · LifeSensors (United States) · funded by National Institutes of Health

$224.8kUbiquitin and proteasome pathways

2019–2021 · research · R43

Rational design of bifunctional protein degrader drugs

Karteek Kadimisetty · LifeSensors (United States) · funded by National Institutes of Health

$299.6kProtein Degradation and Inhibitors

2019–2023 · research · R44

Rational design of bifunctional protein degrader drugs

Karteek Kadimisetty · LifeSensors (United States) · funded by National Institutes of Health

$1MProtein Degradation and Inhibitors

2017–2019 · research · R43

Development of chain selective polyubiquitin markers as early detectors of Parkinson’s and Alzheimer’s Disease

Tauseef R. Butt · LifeSensors (United States) · funded by National Institutes of Health

$190.3kUbiquitin and proteasome pathways

2017–2021 · research · R44

Ubiquitin Proteasome System and Molecular Signatures of Alzheimer’s Disease

Tauseef R. Butt · LifeSensors (United States) · funded by National Institutes of Health

$1MUbiquitin and proteasome pathways

2017–2022 · research · R44

Ubiquitin Proteasome System and Molecular Signatures of Alzheimer's Disease

Tauseef R. Butt · LifeSensors (United States) · funded by National Institutes of Health

$785.3kUbiquitin and proteasome pathways

2016–2018 · research · R43

Linkage-specific ubiquitylation patterns as highly sensitive markers for neurodegenerative disease

Tauseef R. Butt · LifeSensors (United States) · funded by National Institutes of Health

$224.7kUbiquitin and proteasome pathways

2016–2020 · research · R44

Linkage-specific ubiquitylation patterns as highly sensitive markers for neurodegenerative disease

Tauseef R. Butt · LifeSensors (United States) · funded by National Institutes of Health

$718.5kUbiquitin and proteasome pathways

2016–2021 · research · R44

Linkage-specific ubiquitylation patterns as highly sensitive markers for neurodegenerative disease

Tauseef R. Butt · LifeSensors (United States) · funded by National Institutes of Health

$779.7kUbiquitin and proteasome pathways

2016–2018 · research · R43

Novel assays for assessing protein-protein interactions in Alzheimer's disease

Tauseef R. Butt · LifeSensors (United States) · funded by National Institutes of Health

$224.7k